Aquestive Therapeutics Inc investor relations material
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company develops drugs for serious or life-threatening illnesses with unmet need by utilizing its chemistry expertise of developing enzyme inhibitors. It offers lead product ABT-199, which is a potent inhibitor against two enzymes involved in virus replication; and candidates that are being developed for the treatment of disorders related to protein misfolding. Aquestive Therapeutics, Inc. was incorporated in 2004 and is headquartered in Warren, New Jersey.